Screener
Sutro Biopharma STRO Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Sutro Biopharma’s reported figures.
Based on trailing twelve months.
The source filing: Sutro Biopharma’s 10-K, filed March 23, 2026. Open the filing →
- Filed
- Mar 23, 2026, 4:44 PM EDT
- Fiscal year
- FY2025
- Accession
- 0001193125-26-119873
FAQ
- What is Sutro Biopharma's return on equity?
- Sutro Biopharma (STRO) reported return on equity of -234.2% in Q4 2024.
- What is the long-term trend for Sutro Biopharma's return on equity?
- Over 3 years (2020 to 2024), Sutro Biopharma's return on equity has grown at a 150.2% compound annual growth rate (CAGR), from -14.9% to -234.2%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Sutro Biopharma's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude